Toulouse Onco Week
Cell&Co will attend the first Toulouse Onco Week.
The Toulouse Onco Week (TOW) will be held in Toulouse on 3, 4 and 5 february 2016. At the heart of this week dedicated to fight cancer, will be inaugurated the 1st International Symposium of the Cancer Research Center of Toulouse.
5ème Journée de la Recherche Clinique
Organized by the AFCROs and will be held at Issy Les Moulineaux on 4 february 2016.
Meet us at the logistics workshop.
Bioproduction #5 Cell and Gene Therapies B4B-Connection
Cell&Co will attend on 3-4 february 2016 at Evry the 5th anual meeting about the gene and cell biotherapies.
Cell&Co Cell&Co has been glad and proud to support the Cancer Research UK and the Ligue vs Cancer.
We all know someone affected by Cancer around us.
That’s why Steve, Luke and Manu decuded to challenge themselves and raise money to help the Research.
500 miles ride from UK (Abingdon) to France (Montbrison) Against Cancer 2015 that is to say almost 46 hours cycling.
Cell&Co Bioservices is now a member of ISBER (International Society for Biological and Environmental Repositories) and will exhibit at the ISBER 2015, May 5-9, 2015 in Phoenix, Arizona. Visit us at booth #618.
ISBER is a global organization which creates opportunities for sharing ideas and innovations in biobanking and harmonizes approaches to evolving challenges for biological and environmental repositories.
More information on ISBER 2015 website
Cell&Co Bioservices will attend the 13th Partnerships in Clinical Trials Congress on 5-6 November in Barcelona. PCT looks at the outsourcing relationship between pharma and biotech sponsors and providers in clinical trials. Since 2001, they have brought together creators, innovators, storytellers and rising stars to provoke change and demand solutions to the challenge of advancing clinical trial collaborations.
If you like to meet us, please contact us to set up a meeting: email@example.com
Cell&Co is now a member of BIOBANQUES infrastructure. BIOBANQUES Infrastructure take French collection of biological resources to a new level of coordination, quality and efficiency, by setting up a sustainable infrastructure that provide new services, better access for users from public and private sector, develop public private partnerships, interface with the pan European infrastructure BBMRI and EMbaRC/MIRRI and support French biobanks and mBRCs in increasing the value and the use of their collections.
Since its inception, the eco-biobank Cell&Co Bioservices has been committed to extremely high quality standards and has now been awarded ISO 9001:2008 and NF S96-900:2011 certification.
Our solutions for the transport, management and storage of biological resources and our emergency backup service are now ISO 9001:2008 certified. While NF S96-900:2011 certification means that Cell&Co Bioservices’s quality management system meets the standards relevant to biological resource centres.
These two certifications are evidence of the rigorous Quality Assurance system that Cell&Co has put in place and, for our clients, guarantee that our biobank complies with all the quality requirements set out in these standards.
In order to deal with growth in business, Cell&Co has recently recruited 4 new members of staff to strengthen operations:
Eloise Franz holds a professional bachelor’s degree in Quality Assurance and has experience as a quality assistant and laboratory technician
Laëtitia Jouhannet is a microbiology technician with 8 years of experience.
Guillaume Rivrais completed a BTS diploma in Biotechnology with a university course in Cell Biology and previously worked for Genoway in Lyon.
Pierre-Yves Cousin obtained a professional bachelor’s degree in the Chemical and Biotech Industries in 2004 from the University of Paris 6 and has almost 10 years of experience in organizations such as INSERM (the French National Institute for Health and Medical Research) and Genewave.
Photo (from left to right): Laetitia Jouhannet, Pierre-Yves Cousin, Guillaume Rivrais and Eloise Franz
The biobank Cell&Co Bioservices selected to collect and store over a million samples from the ANRS HEPATHER cohort